indirubin-3'-monoxime has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, MY | 1 |
| Liu, YW | 1 |
| Chen, MH | 1 |
| Wu, JY | 1 |
| Ho, HY | 1 |
| Wang, QF | 1 |
| Chuang, JJ | 1 |
1 other study available for indirubin-3'-monoxime and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells.
Topics: Apoptosis; Autophagy; Caspase 3; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; G2 Phas | 2013 |